MSS

21 clinical trials · Condition

Record	Firm	Date
Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer (NCT04659382)	Federation Francophone de Cancerologie Digestive	2020-10-07
QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer (NCT04527068)	Second Affiliated Hospital, Zhejiang University, School of Medicine	2020-09-20
Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma. (NCT04483219)	China Medical University, China	2020-07-24
Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (NCT04046445)	Amal Therapeutics	2019-07-22
Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer (NCT04030260)	Sun Yat-sen University	2019-07-19
Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC (NCT03274804)	University Hospital Heidelberg	2018-04-01
Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation (NCT03271047)	Pfizer	2017-10-18

Every clearance here is in the API, with alerts when new ones post.